Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - AMERICAN SCIENCE & ENGINEERING, INC.Financial_Report.xls
EX-31.1 - EX-31.1 - AMERICAN SCIENCE & ENGINEERING, INC.a12-15644_1ex31d1.htm
EX-32.2 - EX-32.2 - AMERICAN SCIENCE & ENGINEERING, INC.a12-15644_1ex32d2.htm
EX-31.2 - EX-31.2 - AMERICAN SCIENCE & ENGINEERING, INC.a12-15644_1ex31d2.htm
EX-32.1 - EX-32.1 - AMERICAN SCIENCE & ENGINEERING, INC.a12-15644_1ex32d1.htm

Table of Contents

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

x      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2012

 

OR

 

o         TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from      to      

 

Commission File Number 1-6549

 

American Science and Engineering, Inc.

(Exact name of Registrant as specified in its charter)

 

Massachusetts

 

04-2240991

(State or other jurisdiction of

 incorporation or organization)

 

(I.R.S. Employer

 Identification No.)

 

 

 

829 Middlesex Turnpike

 

 

Billerica, Massachusetts

 

01821

(Address of principal executive offices)

 

(Zip Code)

 

(978) 262-8700

 (Registrant’s telephone number, including area code)

 

 

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x  No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x  No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer o

 

Accelerated filer x

 

 

 

Non-accelerated filer o
(Do not check if a smaller reporting company)

 

Smaller reporting company o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934).  Yes o  No x

 

The number of shares of the registrant’s common stock, $0.66 2/3 par value, outstanding as of July 31, 2012 was 8,430,814.

 

 

 



Table of Contents

 

TABLE OF CONTENTS

 

Part I — Financial Information

 

Item 1 — Financial Statements

3

Unaudited Condensed Consolidated Balance Sheets — June 30, 2012 and March 31, 2012

3

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income — For the three months ended June 30, 2012 and June 30, 2011

4

Unaudited Condensed Consolidated Statements of Cash Flows — For the three months ended June 30, 2012 and June 30, 2011

5

Notes to Unaudited Condensed Consolidated Financial Statements

6

Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations

11

Item 3 — Quantitative and Qualitative Disclosure About Market Risk

14

Item 4 — Controls and Procedures

14

Part II — Other Information

 

Item 1A—Risk Factors

14

Item 2 — Unregistered Sales of Equity Securities and Use of Proceeds

14

Item 6 —Exhibits

14

Signatures

16

 

Z Backscatter, ZBV, MobileSearch, Shaped Energy®, AS&E®, Gemini, Omniview, Sentry, SmartCheck®, Z Portal®  and all AS&E product names and AS&E logos are either registered trademarks or trademarks of American Science and Engineering, Inc. in the United States and/or other countries. Other product and company names mentioned herein may be the trademarks of their respective owners.

 

2



Table of Contents

 

PART I — FINANCIAL INFORMATION

ITEM 1 — FINANCIAL STATEMENTS

 

AMERICAN SCIENCE AND ENGINEERING, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

(In thousands, except share and per share amounts) 

 

June 30, 
2012

 

March 31, 
2012

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

9,358

 

$

24,369

 

Restricted cash and investments

 

12,584

 

11,707

 

Short-term investments, at fair value

 

164,202

 

170,834

 

Accounts receivable, net of allowances of $376 and $255 at June 30, 2012 and March 31, 2012, respectively 

 

26,471

 

25,439

 

Unbilled costs and fees

 

8,519

 

3,206

 

Inventories, net

 

46,964

 

48,179

 

Prepaid expenses and other current assets

 

8,065

 

10,386

 

Deferred income taxes

 

3,329

 

3,329

 

Total current assets

 

279,492

 

297,449

 

Building, equipment and leasehold improvements, net

 

17,867

 

17,998

 

Restricted cash and investments

 

1,829

 

4,183

 

Deferred income taxes

 

5,174

 

5,174

 

Other assets, net

 

49

 

61

 

Total assets

 

$

304,411

 

$

324,865

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

7,159

 

$

7,461

 

Accrued salaries and benefits

 

10,511

 

11,722

 

Accrued warranty costs

 

357

 

358

 

Deferred revenue

 

15,270

 

16,731

 

Customer deposits

 

17,500

 

15,031

 

Current portion of lease financing liability

 

1,388

 

1,351

 

Other current liabilities

 

6,169

 

5,989

 

Total current liabilities

 

58,354

 

58,643

 

Lease financing liability, net of current portion

 

4,033

 

4,403

 

Deferred revenue

 

2,641

 

2,913

 

Other long-term liabilities

 

105

 

100

 

Total liabilities

 

65,133

 

66,059

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, no par value, 100,000 shares authorized; no shares issued

 

 

 

Common stock, $0.66 2/3 par value, 20,000,000 shares authorized 8,560,174 and 8,942,793; shares issued and outstanding at June 30, 2012 and March 31, 2012, respectively

 

5,706

 

5,961

 

Capital in excess of par value

 

77,005

 

95,971

 

Accumulated other comprehensive (loss) income, net

 

(19

)

16

 

Retained earnings

 

156,586

 

156,858

 

Total stockholders’ equity

 

239,278

 

258,806

 

Total liabilities and stockholders’ equity

 

$

304,411

 

$

324,865

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3



Table of Contents

 

AMERICAN SCIENCE AND ENGINEERING, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

(Unaudited)

 

 

 

For the Three Months Ended

 

(In thousands, except per share amounts)

 

June 30, 2012

 

June 30, 2011

 

Net sales and contract revenues:

 

 

 

 

 

Net product sales and contract revenues

 

$

25,709

 

$

29,049

 

Net service revenues

 

21,635

 

22,054

 

Total net sales and contract revenues

 

47,344

 

51,103

 

 

 

 

 

 

 

Cost of sales and contracts:

 

 

 

 

 

Cost of product sales and contracts

 

15,124

 

15,221

 

Cost of service revenues

 

10,747

 

11,980

 

Total cost of sales and contracts

 

25,871

 

27,201

 

Gross profit

 

21,473

 

23,902

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

Selling, general and administrative expenses

 

7,998

 

9,258

 

Research and development costs

 

7,115

 

6,077

 

Total operating expenses

 

15,113

 

15,335

 

 

 

 

 

 

 

Operating income

 

6,360

 

8,567

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

Interest and investment income

 

207

 

166

 

Interest expense

 

(20

)

(25

)

Other, net

 

(180

)

(82

)

Total other income

 

7

 

59

 

Income before provision for income taxes

 

6,367

 

8,626

 

Provision for income taxes

 

2,165

 

2,933

 

Net income

 

$

4,202

 

$

5,693

 

Other comprehensive loss:

 

 

 

 

 

Unrealized loss on available for sale securities (net of tax)

 

(36

)

(20

)

Comprehensive income

 

$

4,166

 

$

5,673

 

 

 

 

 

 

 

Income per share

—Basic

 

$

0.47

 

$

0.62

 

 

—Diluted

 

$

0.47

 

$

0.61

 

 

 

 

 

 

 

 

Weighted average shares

—Basic

 

8,853

 

9,193

 

 

—Diluted

 

8,905

 

9,337

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4



Table of Contents

 

AMERICAN SCIENCE AND ENGINEERING, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

For the Three Months Ended

 

(In thousands)

 

June 30,
 2012

 

June 30,
 2011

 

Cash flows from operating activities:

 

 

 

 

 

Net income

 

$

4,202

 

$

5,693

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

Depreciation and amortization

 

1,246

 

1,541

 

Provisions for contracts, inventory and accounts receivable reserves

 

949

 

33

 

Amortization of bond premium

 

769

 

556

 

Deferred income taxes

 

 

466

 

Other

 

(1

)

 

Stock compensation expense

 

258

 

607

 

Changes in assets and liabilities:

 

 

 

 

 

Accounts receivable

 

(1,153

)

9,671

 

Unbilled costs and fees

 

(5,313

)

(4,121

)

Inventories

 

387

 

(1,779

)

Prepaid expenses and other assets

 

2,333

 

(2,482

)

Accounts payable

 

(302

)

(483

)

Accrued income taxes

 

 

553

 

Customer deposits

 

2,469

 

8,848

 

Deferred revenue

 

(1,733

)

3,446

 

Accrued expenses and other liabilities

 

(1,027

)

(8,526

)

Net cash provided by operating activities

 

3,084

 

14,023

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

Purchases of short-term investments

 

(31,513

)

(90,577

)

Proceeds from sales and maturities of short-term investments

 

37,341

 

52,069

 

Purchases of property and equipment, net

 

(1,114

)

(2,103

)

Net cash provided by (used for) investing activities

 

4,714

 

(40,611

)

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

Decrease in restricted cash and investments

 

1,477

 

15,385

 

Proceeds from exercise of stock options

 

112

 

2,833

 

Repurchase of shares of common stock

 

(19,591

)

(22

)

Repayment of leasehold financing liability

 

(333

)

(330

)

Payment of common stock dividend

 

(4,474

)

(2,760

)

Change in income taxes paid due to the tax benefit from employee stock option expense

 

 

262

 

Net cash (used for) provided by financing activities

 

(22,809

)

15,368

 

 

 

 

 

 

 

Net decrease in cash and cash equivalents

 

(15,011

)

(11,220

)

Cash and cash equivalents at beginning of period

 

24,369

 

60,144

 

Cash and cash equivalents at end of period

 

$

9,358

 

$

48,924

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

5



Table of Contents

 

AMERICAN SCIENCE AND ENGINEERING, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

1.   GENERAL

 

The condensed consolidated financial statements include the accounts of American Science and Engineering, Inc. and its wholly owned subsidiaries (the “Company”). All significant intercompany transactions and balances have been eliminated.

 

The unaudited condensed consolidated financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include all disclosures required by Form 10-K. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2012, or fiscal 2012, as filed with the Securities and Exchange Commission on June 8, 2012.

 

The unaudited condensed consolidated financial statements, in the opinion of management, include all necessary adjustments, consisting solely of normal recurring adjustments, to present fairly the Company’s financial position, results of operations and cash flows.  These results are not necessarily indicative of the results to be expected for the entire year.

 

Nature of Operations

 

The Company develops, manufactures, markets, and sells X-ray inspection and other detection products for homeland security and other targeted markets.  The Company provides maintenance, warranty, engineering, and training services related to these products.  The Company has one reporting segment, X-ray screening products.

 

Significant Accounting Policies

 

For systems that are produced in a standard manufacturing operation and have shorter order to delivery cycles, the Company recognizes sales when title passes and when other revenue recognition criteria (such as transfer of risk and customer acceptance) are met.  Revenues on cost reimbursable and custom long-term fixed price contracts are generally recorded as costs are incurred using the percentage of completion method.

 

Occasionally, the Company receives requests from customers to hold product being purchased for a valid business purpose. The Company recognizes revenue for such arrangements provided the transaction meets, at a minimum, the following criteria: a valid business purpose for the arrangement exists; risk of ownership of the purchased product has transferred to the buyer; there is a fixed delivery date that is reasonable and consistent with the buyer’s business purpose; the product is ready for shipment; the Company has no continuing performance obligation in regards to the product and the product has been segregated from the Company’s inventories and cannot be used to fill other orders received.  There was no product being held under such arrangements at June 30, 2012 or March 31, 2012.

 

The other significant accounting policies followed by the Company and its subsidiaries in preparing its consolidated financial statements are set forth in Note 1 to the consolidated financial statements included in its Form 10-K for the year ended March 31, 2012.  There have been no changes to our critical accounting policies during the three months ended June 30, 2012.

 

Stock Repurchase Program

 

In May 2012, the Board of Directors approved a new Stock Repurchase Program which authorized the Company to repurchase up to $35.0 million of shares of its common stock from time to time on the open market.  During the three months ended June 30, 2012, a total of 384,000 shares were repurchased and retired at an average price of $51.02 per share.  As of June 30, 2012, the maximum dollar value of shares that may still be purchased under this program was $15,390,000.

 

On August 2, 2012, the Board of Directors announced the approval of an additional Stock Repurchase Program which authorizes the Company to repurchase up to $35 million of shares of its common stock from time to time on the open market or in privately negotiated transactions.

 

Dividends

 

 

 

Three Months Ended

 

(In thousands)

 

June 30, 2012

 

June 30, 2011

 

Dividends declared

 

$

0.50

 

$

0.30

 

Dividends paid

 

$

0.50

 

$

0.30

 

 

6



Table of Contents

 

On August 2, 2012, the Company declared a cash dividend of $0.50 per share. The dividend will be paid on September 4, 2012 to all shareholders of record at the close of business on August 22, 2012.  Future dividends will be declared at the discretion of the Board of Directors and will depend upon such factors as the Board of Directors deems relevant.

 

Concentrations of Credit Risk

 

Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, restricted cash, short-term investments and accounts and unbilled receivables.  At times, the Company maintains cash balances in excess of insured limits. The Company maintains its cash and cash equivalents with major financial institutions.  The Company’s credit risk is managed by investing its cash in investment grade corporate debentures / bonds, U.S. government agency bonds, commercial paper, U.S. treasury bills, money market funds, and certificates of deposit.

 

2.   ACCOUNTING FOR STOCK-BASED COMPENSATION

 

The Company accounts for stock-based awards made to its employees and Board of Directors in accordance with FASB ASC 718, Compensation—Stock Compensation, which requires the measurement and recognition of all compensation costs for stock-based awards made to employees and the Board of Directors based upon fair value over the requisite service period for awards expected to vest.

 

The Company recognized $258,000 and $607,000 of stock-based compensation costs in the consolidated statements of operations and comprehensive income for the three months ended June 30, 2012 and June 30, 2011, respectively. The income tax benefit recognized related to the compensation costs for the three months ended June 30, 2012 and June 30, 2011 was approximately $88,000 and $207,000, respectively.

 

The following table summarizes stock-based compensation costs included in the Company’s consolidated statement of operations and comprehensive income:

 

 

 

Three months ended

 

(In thousands)

 

June 30, 2012

 

June 30, 2011

 

Cost of revenues

 

$

58

 

$

106

 

Selling, general and administrative expenses

 

200

 

501

 

Total stock-based compensation expense before tax

 

$

258

 

$

607

 

 

Stock Option and Other Compensation Plans

 

The Company has various stock option and other compensation plans for non-employee directors, officers, and employees. The Company had the following stock option and other compensation plans outstanding as of June 30, 2012: the 1995 Combination Plan, the 1997 Non-Qualified Option Plan, the 1998 Non-Qualified Option Plan, the 1999 Combination Plan, the 2000 Combination Plan, the 2002 Combination Plan, the 2003 Stock Plan for Non-Employee Directors and the 2005 Equity and Incentive Plan. There are 3,980,000 shares authorized under these plans. As of June 30, 2012, 275,000 shares remain available for future issuance under these plans.  Vesting periods for awards granted under such plans are at the discretion of the Compensation Committee of the Board of Directors, or their designee, and typically range between one and three years. Options under these plans are granted at fair market value and have a term of ten years from the date of grant.

 

Stock Options

 

The following tables summarize stock option activity for the three months ended June 30, 2012:

 

 

 

Number of
Shares

 

Weighted
Average
Exercise
Price ($)

 

Weighted
Average
Contractual
Life
(years)

 

Aggregate
Intrinsic

Value

 

Options outstanding at March 31, 2012

 

376,331

 

$

55.10

 

4.59

 

 

 

Grants

 

 

 

 

 

 

 

Exercises

 

(2,871

)

39.06

 

 

 

$

33,000

 

Cancellations

 

 

 

 

 

 

 

Options outstanding at June 30, 2012

 

373,460

 

$

55.22

 

4.35

 

$

2,572,000

 

Options exercisable at June 30, 2012

 

367,529

 

$

55.12

 

4.39

 

 

 

 

Information related to the stock options outstanding as of June 30, 2012 is as follows:

 

7



Table of Contents

 

Range of Exercise Prices

 

Number of
Shares

 

Weighted-
Average

Remaining
Contractual
Life (years)

 

Weighted-
Average

Exercise Price
($)

 

Exercisable
Number of
Shares

 

Exercisable
Weighted-
Average

Exercise Price
($)

 

$  8.00 - $20.00

 

22,992

 

1.38

 

$

13.19

 

22,992

 

$

13.19

 

$20.01 - $30.00

 

19,750

 

2.21

 

28.50

 

19,750

 

28.50

 

$30.01 - $40.00

 

17,629

 

2.43

 

39.06

 

17,629

 

39.06

 

$40.01 - $50.00

 

39,600

 

3.30

 

44.77

 

39,600

 

44.77

 

$50.01 - $60.00

 

78,695

 

3.02

 

53.23

 

78,695

 

53.23

 

$60.01 - $70.00

 

138,613

 

4.91

 

64.21

 

132,682

 

64.33

 

$70.01 - $75.82

 

56,181

 

8.17

 

74.87

 

56,181

 

74.87

 

$  8.00 - $75.82

 

373,460

 

4.35

 

$

55.22

 

367,529

 

$

55.12

 

 

The Company deems the Black-Scholes option pricing model as the most appropriate method for determining the estimated fair value of stock-based awards. The Black-Scholes method of valuation requires several assumptions: (1) the expected term of the stock-based award; (2) the expected future stock volatility over the expected term; (3) a risk-free interest rate; and (4) the expected dividend yield. The expected term represents the expected period of time the Company believes the options will be outstanding based on historical information. Estimates of expected future stock price volatility are based on the historic volatility of the Company’s common stock and the risk free interest rate is based on the U.S. Zero-Bond rate. The expected dividend yield is based on the assumption that the Company would continue paying dividends on its common stock at the same rate for the foreseeable future.

 

There were no options granted in the three month periods ended June 30, 2012 or June 30, 2011.

 

As of June 30, 2012, there was approximately $11,000 of unrecognized compensation costs related to options granted. This cost is expected to be recognized over a weighted average period of 1.3 years.  Non-vested common stock options are subject to the risk of forfeiture until the fulfillment of specified conditions.

 

Restricted Stock and Restricted Stock Units

 

The Company has instituted long-term incentive plans for certain key employees. These plans call for the issuance of restricted stock, restricted stock options, and/or cash incentives which vest or are paid upon the achievement of certain performance-based goals as well as service time incurred.  Restricted stock and restricted stock units may also be granted to other employees with vesting periods that range from one to three years.  In addition, annually the Board of Directors is granted restricted stock. These restricted stock shares vest on a pro-rata basis on service time performed over a one-year period.  The fair values of these restricted stock awards are equal to the market price per share of the Company’s common stock on the date of grant.

 

Non-vested restricted stock and stock unit awards are subject to the risk of forfeiture until the fulfillment of specified conditions. As of June 30, 2012 there was $963,000 of total unrecognized compensation cost related to non-vested restricted stock and stock unit awards granted under the Company’s stock plans. This cost is expected to be recognized over a weighted average period of less than one year.

 

The following table summarizes the status of the Company’s non-vested restricted stock and stock unit awards for the three months ended June 30, 2012:

 

 

 

Number of
Shares

 

Weighted Average
Grant Date
Fair Value
($)

 

Outstanding at March 31, 2012

 

40,599

 

$

68.63

 

Granted

 

4,500

 

58.93

 

Vested

 

(6,965

)

76.32

 

Forfeited

 

 

 

Outstanding at June 30, 2012

 

38,134

 

$

66.08

 

 

3.   INVENTORIES

 

Inventories consist of material, labor and manufacturing overhead and are recorded at the lower of cost, using the weighted average cost method, or net realizable value. Excess manufacturing overhead costs attributable to idle facility expenses, freight, handling costs and wasted material (spoilage) attributable to abnormally low production volumes (levels that materially differ

 

8



Table of Contents

 

from budgeted production plans due primarily to changes in customer demand) are excluded from inventory and recorded as an expense in the period incurred.

 

The components of inventories at June 30, 2012 and March 31, 2012 were as follows:

 

(In thousands)

 

June 30,
2012

 

March 31,
2012

 

Raw materials, completed sub-assemblies, and spare parts

 

$

22,997

 

$

23,689

 

Work-in-process

 

17,436

 

16,705

 

Finished goods

 

6,531

 

7,785

 

Total

 

$

46,964

 

$

48,179

 

 

4.   INCOME PER COMMON AND COMMON EQUIVALENT SHARE

 

Basic earnings per common share is computed by dividing net income available to common stockholders by the weighted average number of shares of common stock outstanding during the period.  Diluted earnings per share include the dilutive impact of options and restricted stock units using the average share price of the Company’s common stock for the period. For the three months ended June 30, 2012 and June 30, 2011, common stock equivalents of 202,000 and 2,000, respectively, are excluded from diluted earnings per share, as their effect is anti-dilutive.

 

 

 

Three Months Ended

 

(In thousands except per share amounts)

 

June 30, 
2012

 

June 30, 
2011

 

Earnings Per Share - Basic:

 

 

 

 

 

Net income

 

$

4,202

 

$

5,693

 

Weighted average number of common shares outstanding — basic

 

8,853

 

9,193

 

Net income per share — basic

 

$

0.47

 

$

0.62

 

Earnings Per Share - Diluted:

 

 

 

 

 

Net income

 

$

4,202

 

$

5,693

 

Weighted average number of common shares outstanding

 

8,853

 

9,193

 

Assumed exercise of stock options and restricted stock units, using the treasury stock method

 

52

 

144

 

Weighted average number of common and potential common shares outstanding — diluted

 

8,905

 

9,337

 

Net income per share — diluted

 

$

0.47

 

$

0.61

 

 

5.   LETTERS OF CREDIT

 

In the normal course of business, the Company may provide certain customers and potential customers with performance guarantees, which are generally backed by standby letters of credit. In general, the Company would only be liable for the amount of these guarantees in the event of default in the performance of its obligations; the probability of which management believes is low.  As of June 30, 2012, the Company had outstanding $27,147,000 in standby letters of credit.  These outstanding standby letters of credit are cash-secured at amounts ranging from 52% to 69% of the outstanding letters of credit, resulting in a restricted cash balance of $14,413,000 at June 30, 2012 of which $1,829,000 was considered long-term restricted cash due to the expiration date of the underlying letters of credit.

 

6.   FAIR VALUE MEASUREMENTS

 

The Company has categorized its financial assets, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy as set forth below. If the inputs used to measure a financial instrument fall within different levels of the hierarchy, the categorization of such financial asset is based on the lowest level input that is significant to the fair value measurement of such instrument.

 

Financial assets recorded on the Condensed Consolidated Balance Sheets are categorized based on the inputs to the valuation techniques as follows:

 

Level 1 - Financial assets whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access at the measurement date (examples include actively exchange-traded equity securities, listed derivatives, and most U.S. government and agency securities).

 

Level 2 - Financial assets whose values are based on quoted prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets.  Level 2 inputs include the following:

 

9



Table of Contents

 

·             Quoted prices for identical or similar assets or liabilities in non-active markets;

 

·             Inputs other than quoted prices that are observable for substantially the full term of the asset or liability; and

 

·             Inputs that are derived principally from or corroborated by observable market data for substantially the full term of the asset or liability.

 

Level 3 - Financial assets whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s assumptions about the assumptions a market participant would use in pricing the asset or liability. The Company currently does not have any Level 3 financial assets or liabilities.

 

The following table presents the financial assets and liabilities the Company measures at fair value on a recurring basis, based on the fair value hierarchy as of June 30, 2012 and March 31, 2012:

 

(In thousands)

 

June 30,
2012

 

March 31, 
2012

 

Level 1 — Financial Assets

 

 

 

 

 

U.S. Treasury bills

 

$

15,008

 

$

20,018

 

Level 2 — Financial Assets

 

 

 

 

 

Corporate debentures/bonds

 

85,513

 

78,169

 

Commercial paper

 

45,550

 

40,334

 

Government agency bonds

 

12,410

 

26,582

 

Certificates of deposit

 

5,721

 

5,731

 

Money market funds

 

480

 

13,698

 

Total Level 2 Financial Assets

 

149,674

 

164,514

 

Total cash equivalents and short-term investments

 

$

164,682

 

$

184,532

 

 

These investments are classified as available-for-sale and are recorded at their fair market values using the specific identification method. As of June 30, 2012, all of the Company’s available-for-sale securities had contractual maturities of twelve months or less. The Company had no material realized gains or losses on its available-for-sale securities for the three months ended June 30, 2012 and June 30, 2011, respectively. The unrealized holding gains or losses on these securities are included as a component of other comprehensive income, as disclosed in the condensed consolidated statements of operations and comprehensive income.

 

 

 

Amortized 
Cost

 

Gross 
Unrealized 
Gains

 

Gross 
Unrealized 
Losses

 

Fair Value

 

June 30, 2012

 

 

 

 

 

 

 

 

 

Short-term investments:

 

 

 

 

 

 

 

 

 

Corporate debentures/bonds

 

$

85,535

 

$

6

 

$

(28

)

$

85,513

 

Commercial paper

 

45,549

 

1

 

 

45,550

 

Government agency bonds

 

12,409

 

1

 

 

12,410

 

U.S. Treasury bills

 

14,998

 

10

 

 

15,008

 

Certificates of deposit

 

5,722

 

 

(1

)

5,721

 

Total short-term investments

 

$

164,213

 

$

18

 

$

(29

)

$

164,202

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

Money market funds

 

$

480

 

$

 

$

 

$

480

 

 

 

 

Amortized 
Cost

 

Gross 
Unrealized 
Gains

 

Gross 
Unrealized 
Losses

 

Fair Value

 

March 31, 2012:

 

 

 

 

 

 

 

 

 

Short-term investments:

 

 

 

 

 

 

 

 

 

Corporate debentures/bonds

 

$

78,176

 

$

21

 

$

(28

)

$

78,169

 

Commercial paper

 

40,331

 

3

 

 

40,334

 

Government agency bonds

 

26,573

 

9

 

 

26,582

 

Treasury bills

 

20,000

 

18

 

 

20,018

 

Certificates of deposit

 

5,729

 

2

 

 

5,731

 

Total short-term investments

 

$

170,809

 

$

53

 

$

(28

)

$

170,834

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

Money market funds

 

$

13,698

 

 

 

13,698

 

 

10



Table of Contents

 

7.   INCOME TAXES

 

The Company accounts for income taxes in accordance with FASB ASC 740, Income Taxes and recognizes deferred income taxes based on the expected future tax consequences of differences between the financial statement basis and the tax basis of assets and liabilities, calculated using enacted tax rates in effect for the year in which the differences are expected to be reflected in the tax return. The Company evaluates the need for a valuation allowance against its net deferred tax assets at year end based upon its three year cumulative income and its projections of future income, and records a valuation allowance against any net deferred tax assets if it is more likely than not that they will not be realized.

 

The Company is currently open to audit under the statute of limitations by the Internal Revenue Service for the years ending March 31, 2009 through 2011 and for various state taxing authorities for the years ending March 31, 2006 through 2011.  The Company believes that there were no material uncertain tax positions that required a reserve as of June 30, 2012.

 

8.     GUARANTEES

 

Certain of the Company’s products carry a one-year warranty, the costs of which are accrued for at the time of shipment or delivery.  Accrual rates are based upon historical experience for the trailing twelve months and management’s judgment of future exposure.  Warranty experience for the three months ended June 30, 2012 and 2011 was as follows:

 

 

 

Three Months Ended

 

(In thousands)

 

June 30, 2012

 

June 30, 2011

 

Warranty accrual at beginning of period

 

$

358

 

$

1,225

 

Accruals for warranties issued during the period

 

123

 

307

 

Adjustment of preexisting accrual estimates

 

96

 

12

 

Warranty costs incurred during period

 

(220

)

(430

)

Warranty accrual at end of period

 

$

357

 

$

1,114

 

 

9.   LEASE COMMITMENTS

 

In March 2005, the Company renewed its lease agreement for its corporate headquarters and manufacturing facilities in Billerica, Massachusetts.  As part of the lease agreement, the Company’s landlord agreed to certain renovations to the Billerica facility including the construction of additional high bay manufacturing space.  The Company was responsible for a portion of the construction costs and was deemed to be the owner of the building during the construction period under FASB ASC 840, Leases.  In January 2007, the Company amended this lease agreement to expand its lease to include the remaining available space in the building.  A total of $7,182,000 was capitalized to record the facility on its books with an offsetting credit to the lease financing liability.  In addition, amounts paid for construction were capitalized to fixed assets and the landlord construction allowances of $6,009,000 were recorded as additional lease financing liability.

 

At the completion of the construction of the initial renovations in February 2006, the lease was reviewed for potential sale-leaseback treatment in accordance with FASB ASC 840-40, Leases — Sale-Leaseback Transactions.  Based on this review, it was determined that the lease did not qualify for sale-leaseback treatment in accordance with FASB ASC 840-40.  As a result, the building and tenant improvement and associated lease financing liabilities remain on the Company’s books.  The lease financing liability is being amortized over the lease term based on the payments designated in the agreement and the building and tenant improvement assets are being depreciated on a straight line basis over the lesser of their useful lives or the lease term.

 

10.   COMMITMENTS AND CONTINGENCIES

 

Deferred Revenue

 

The Company offers to its customers extended warranty and service contracts. These contracts typically cover a period of one to five years, and include advance payments that are recorded as deferred revenue. Revenue is recognized as services are performed over the life of the contract, which represents the period over which these revenues are earned. Costs associated with these extended warranty and service contracts are expensed to cost of goods sold as incurred.

 

ITEM 2 — MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

This Quarterly Report on Form 10-Q contains forward-looking statements that involve risks and uncertainties. For this

 

11



Table of Contents

 

purpose, any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934.  Without limiting the foregoing, the words “believes”, “anticipates”, “plans”, “expects”, “intends”, “should” and similar expressions are intended to identify forward-looking statements.  These statements are not guarantees of future performance and involve certain risks, uncertainties, and assumptions that are difficult to predict, and you should not place undue reliance on our forward-looking statements.  The factors discussed under “Item 1A. Risk Factors”, among others, could cause actual results to differ materially from those indicated by forward-looking statements made herein and presented elsewhere by management from time to time.  We expressly disclaim any obligation to update or alter our forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

Overview

 

American Science and Engineering, Inc., which is referred to in this report as “we” or “the Company”, develops, manufactures, markets, and sells X-ray inspection and other detection products for homeland security and other targeted markets.  The Company provides maintenance, warranty, engineering, and training services related to these products.

 

Our primary technologies are Z Backscatter technology which is used to detect explosives, illegal drugs, and other contraband even when artfully concealed in complex backgrounds, and other technologies that expand the detection capability of our products beyond the material discrimination features of the Z Backscatter technology to include the penetration capability of high-energy transmission X-rays and/or other detection techniques, such as radioactive threat detection.

 

Net sales and contract revenues for the first quarter of fiscal year ending March 31, 2013, or fiscal 2013, decreased to $47,344,000 compared to revenues of $51,103,000 for the first quarter of fiscal 2012. We reported operating income of $6,360,000 for the first quarter of fiscal 2013 compared to $8,567,000 for the first quarter of fiscal 2012.  Net income for the first quarter of fiscal 2013 was $4,202,000 ($0.47 per share, on a diluted basis) compared to net income of $5,693,000 ($0.61 per share, on a diluted basis) for the first quarter of fiscal 2012. These results represent a 7% decrease in revenues, a 26% decrease in net income, and a $0.14 decrease in earnings per share when compared to results for the first quarter of the fiscal 2012.

 

Critical Accounting Policies

 

We believe that several accounting policies are important to understanding our historical and future performance. We refer to these policies as “critical” because these specific areas generally require us to make judgments and estimates about matters that are uncertain at the time we make the estimate, and different estimates—which also would have been reasonable—could have been used, which would have resulted in different financial results.

 

The critical accounting policies we identified in our most recent Annual Report on Form 10-K for the fiscal year ended March 31, 2012 are policies related to revenue recognition, inventories and related allowances for obsolete and excess inventory, and income taxes. It is important that the discussion of our operating results that follows be read in conjunction with the critical accounting policies disclosed in our Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on June 8, 2012.  There have been no changes to our critical accounting policies during the three months ended June 30, 2012.

 

Results of Operations

 

Net revenues for the first quarter of fiscal 2013 decreased by $3,759,000 to $47,344,000 compared to the revenues of $51,103,000 for the first quarter of fiscal 2012.  This decrease is attributable primarily to a decrease of $3,340,000 in product sales and contract revenues from the same period a year ago.  This decrease was due primarily to a decrease of $11,683,000 in Parcel and Personnel Inspection system revenues.  In the first quarter of fiscal 2012, the Company fulfilled one large multi-unit Parcel and Personnel Inspection system order which was not repeated in the first quarter of fiscal 2013.  This decrease was offset by an increase of $7,872,000 in Cargo Inspection system revenues as compared to the corresponding prior year period due to an increase in the number of systems accepted in the period as compared to the prior period.  Contract research and development, Z Backscatter Systems and aftermarket parts revenues remained relatively flat as compared to the prior period.  Service revenues decreased by $419,000 to $21,635,000 compared to the first quarter of fiscal 2012 due primarily to a decrease in fixed price service contract revenue from the prior year.

 

Total cost of sales and contracts for the first quarter of fiscal 2013 decreased by $1,330,000 to $25,871,000 as compared to the corresponding period a year ago. Cost of sales and contracts related to product revenues decreased by $97,000 to $15,124,000 as compared to the corresponding period a year ago.  Cost of product sales and contract revenues represented 59% of revenues versus 52% of revenues for the corresponding period in the prior year.  The resultant decrease in gross margin percentage from the prior year is due primarily to accruals for losses on certain long-term contracts provided for in the period and inventory reserves accrued during the period.  The cost of service revenues for the quarter ended June 30, 2012 decreased by $1,233,000 to $10,747,000 as compared to the corresponding period a year ago.  Cost of service revenues decreased to 50% of revenues from 54% of revenues in the corresponding period due primarily to a reduction in third party services required to support systems under

 

12



Table of Contents

 

contract during the period.

 

Selling, general and administrative expenses for the first quarter of fiscal 2013 decreased by $1,260,000 to $7,998,000 as compared to the corresponding period a year ago.  Selling, general and administrative expenses represented 17% of revenues in the current period compared to 18% for the corresponding period in the prior year.  The decrease in selling, general and administrative expenses from the prior period was primarily the result of a decrease in incentive compensation expense of $551,000, a decrease in payroll and payroll-related costs of $256,000 attributable to decreased headcount and a decrease in marketing related costs of $319,000.

 

Company funded research and development expenses for the first quarter of fiscal 2013 increased by $1,038,000 to $7,115,000 as compared to the corresponding period a year ago.  Research and development expenses represented 15% of revenues in the current quarter compared to 12% for the corresponding period in the prior year. Research and development expenses increased as compared to the prior period due to an increase in labor resources focused on research and development programs and an increase in subcontracted engineering services during the period related primarily to one current research and development program.  Research and development activities performed in the quarter focused on the development of new products, product options and product enhancements.

 

Other income (expense) was $7,000 of income for the first quarter of fiscal 2013 as compared to $59,000 of income for the corresponding period a year ago.

 

We reported pre-tax income of $6,367,000 in the first quarter of fiscal 2013 as compared to pre-tax income of $8,626,000 in the corresponding period due to the factors described above.

 

Our effective tax rate remained constant at 34% for both the three months ended June 30, 2012 and for the corresponding period a year ago.

 

We had net income of $4,202,000 for the first quarter of fiscal 2013 as compared to net income of $5,693,000 in the first quarter of fiscal 2012.  The significant factors contributing to these results are noted in the above sections.

 

Liquidity and Capital Resources

 

Our sources of capital include, but are not limited to, our cash flows from operations and cash received from stock issuances related to option exercises.  We believe that our operating cash flows and cash and investments on hand are sufficient to fund our working capital requirements, capital expenditures, income tax obligations, dividends to our shareholders and performance guarantee collateralizations for the foreseeable future and also to fund stock repurchases as desired.

 

Summary of Cash Activities

 

Cash and cash equivalents decreased by $15,011,000 to $9,358,000 at June 30, 2012 compared to $24,369,000 at March 31, 2012. This decrease is attributable primarily to:

 

1)             the repurchase of 384,000 shares of the Company’s common stock for $19,591,000 during the period;

2)             an increase in unbilled costs and fees of $5,313,000 during the period due to the timing of invoicing on certain fixed priced contracts;

3)             the payment of $4,474,000 in common stock dividends during the year as part of our quarterly dividend program; and

4)             net capital expenditures of $1,114,000 during the period attributable primarily to software and equipment purchases, and leasehold improvements made during the period.

 

Offsetting these outflows were other cash inflows including:

 

1)             net income of $4,202,000 for the period adjusted for $3,221,000 in non-cash expenditures which included depreciation expense, stock based compensation, contract losses and inventory and accounts receivable reserves;

2)             net proceeds from sales and maturities of short-term investments of $5,828,000;

3)             a net decrease of $1,477,000 in restricted cash and investments due to a decrease in the amount of outstanding letters of credit; and

4)             an increase of $2,469,000 in customer deposits during the period due to the timing of milestone payments on certain fixed price contracts.

 

In the normal course of business, we may provide certain customers and potential customers with performance guarantees, which are generally backed by standby letters of credit. In general, we would only be liable for the amount of these guarantees in the event of default in the performance of our obligations; the probability of which management believes is low.  As of June 30, 2012, we had outstanding $27,147,000 in standby letters of credit.  These outstanding standby letters of credit are cash-secured at

 

13



Table of Contents

 

amounts ranging from 52% to 69% of the outstanding letters of credit, resulting in a restricted cash balance of $14,413,000 at June 30, 2012 of which $1,829,000 was considered long-term restricted cash due to the expiration date of the underlying letters of credit.

 

ITEM 3 — QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

There were no material changes in the quantitative and qualitative information about market risk since the end of our most recent fiscal year.  For further information, see Item 7A of our Annual Report on Form 10-K for the fiscal year ended March 31, 2012, as filed with the Securities and Exchange Commission on June 8, 2012.

 

ITEM 4 — CONTROLS AND PROCEDURES

 

a)   Evaluation of disclosure controls and procedures

 

As of the end of the period covered by this report, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, the Company reviewed and evaluated the effectiveness of the Company’s disclosure controls and procedures pursuant to Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 as amended (the “Exchange Act”). Based upon their evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by the Company in the reports filed and submitted by it under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and to provide reasonable assurance that information required to be disclosed by the Company in such reports is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

 

b)   Changes in internal control over financial reporting

 

There have been no changes in our internal control over financial reporting as such term is defined in Rule 13a-15(f) and 15d-15(f) of the Exchange Act during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

PART II — OTHER INFORMATION

 

ITEM 1A — RISK FACTORS

 

You should carefully review and consider the information regarding certain factors which could materially affect our business, financial condition or future results set forth under Item 1A. “Risk Factors” in our Form 10-K for the fiscal year ended March 31, 2012 as filed with the Securities and Exchange Commission on June 8, 2012. There have been no material changes from the factors disclosed in our Form 10-K for the year ended March 31, 2012, although we may disclose changes to such factors or disclose additional factors from time to time in our future filings with the Securities and Exchange Commission.

 

ITEM 2 — UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

The following table provides information about our purchases during the quarter ended June 30, 2012 of equity securities that are registered by us pursuant to Section 12 of the Exchange Act.

 

Quarter ended June 30, 2012

 

Total Number 
of Shares 
Purchased

 

Average 
Price Paid 
per Share

 

Total Number of 
Shares 
Purchased as 
Part of Publicly 
Announced 
Programs (1)

 

Approximate 
Dollar Value of 
Shares that May 
Yet Be Purchased 
Under the 
Programs

 

April 1 — April 30

 

 

$

 

 

$

35,000,000

 

May 1 — May 31

 

125,000

 

48.58

 

125,000

 

$

28,921,000

 

June 1 — June 30

 

259,000

 

52.19

 

259,000

 

$

15,390,000

 

Total

 

384,000

 

$

51.02

 

384,000

 

$

15,390,000

 

 


(1)                                 On May 14, 2012, the Board of Directors announced the approval of a new Stock Repurchase Program which authorized the Company to purchase up to $35 million of shares of its common stock from time to time on the open market or in privately negotiated transactions.  This Stock Repurchase Program has no specified expiration date.

 

ITEM 6 — EXHIBITS

 

The exhibits listed on the Exhibit Index immediately following the signature page to this Quarterly Report on Form 10-Q are incorporated herein by reference, and are filed or furnished as part of this Quarterly Report on Form 10-Q.

 

14



Table of Contents

 

The information required by Exhibit Item 11 (Statement re: Computation of Income per Common and Common Equivalent Share) may be found in Note 4 to the Unaudited Condensed Consolidated Financial Statements in this quarterly report.

 

15



Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

AMERICAN SCIENCE AND ENGINEERING, INC.

 

 

Date: August 8, 2012

/s/ Kenneth J. Galaznik

 

Kenneth J. Galaznik

 

Senior Vice President, Chief Financial Officer, Treasurer and Clerk
(Principal Financial Officer)

 

16



Table of Contents

 

EXHIBIT INDEX

 

Exhibit
Number

 

Description of Exhibits

 

 

 

31.1

 

Certification by Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

31.2

 

Certification by Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

32.1

 

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

32.2

 

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

101

 

The following financial information from American Science and Engineering Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012, formatted in XBRL (eXtensible Business Reporting Language) includes: (i) Condensed Consolidated Statements of Operations and Comprehensive Income for the three months ended June 30, 2012 and 2011, (ii) Condensed Consolidated Balance Sheets at June 30, 2012 and March 31, 2012, (iii) Condensed Consolidated Statements of Cash Flows for the three months ended June 30, 2012 and 2011, and (iv) the Notes to Condensed Consolidated Financial Statements.

 

17